Effectiveness of empagliflozin in reducing hypoglycemic events as compared to sulfonylurea in type 2 diabetes patients during fasting in Ramadan: a single-center study. [PDF]
Kiran Z +5 more
europepmc +1 more source
Identifying high-risk combinations of metformin during COVID-19. [PDF]
Dimnjaković J +5 more
europepmc +1 more source
The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities. [PDF]
Zou C +5 more
europepmc +1 more source
Use of Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study. [PDF]
Engström A +10 more
europepmc +1 more source
Controllable Ion-Repulsion Enables Rapid and Trace-Level Detection of Hydrophobic Sulfonylurea Herbicides with ICPMS/MS without the Organic Mode. [PDF]
Lajin B, Goessler W.
europepmc +1 more source
ArcDFI: Attention regularization guided by CYP450 interactions for predicting drug-food interactions. [PDF]
Gim M, Kang J, Park D, Jeon M.
europepmc +1 more source
Medications Associated with Increased Risk of Hypoglycemia in Older Adults on Sulfonylureas: A High-Throughput Case-Crossover-Based Screening Study. [PDF]
Bea S +5 more
europepmc +1 more source
Combined In Vitro and Computational Investigations on Synthesized Sulfonamide-Based Antidiabetic Agents. [PDF]
Iacob AD +9 more
europepmc +1 more source
Effect of antidiabetic medication adherence on risk of all-cause mortality and cardiovascular diseases in type 2 diabetes patients: Impact of antidiabetic adherence on cardiovascular disease. [PDF]
Seo DH, Ha KH, Kim SH, Kim DJ.
europepmc +1 more source
Blood Pressure Status Modulates the Therapeutic Response to Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial. [PDF]
Ishibashi R +6 more
europepmc +1 more source

